A Cross-Sectional Study of 100 Patients with Chronic Obstructive Pulmonary Disease and Their Relationship to Bronchodilators

COPD is a progressive respiratory condition characterized by airflow limitation and breathing difficulties, primarily involving chronic bronchitis and emphysema. The paper highlights the importance of bronchodilators in managing COPD by improving lung function, reducing symptoms, and enhancing quality of life. Due to that, our study presented a cross-sectional study that analyses and assesses the outcomes of 100 patients with chronic obstructive pulmonary disease (COPD) and their relationship to bronchodilators in different hospitals in Iraq. Als the study also assessed the impact of bronchodilators on the quality of life of COPD patients using the St. George's Respiratory Questionnaire (SGRQ-C) which our study depended on bronchodilators are medications commonly used to treat COPD patients by relaxing the muscles in the airways, allowing for improved airflow and easier breathing. Combination therapy (bronchodilators) with other medication classes, such as inhaled corticosteroids, is often used for the comprehensive management of COPD. The study found that combination therapy with bronchodilators and inhaled corticosteroids showed better outcomes in terms of symptom control and preventing exacerbations. Our results enrolled that combination therapy with bronchodilators and inhaled corticosteroids showed better outcomes in terms of symptom control and preventing exacerbations. In addition, the use of inhaled corticosteroids (ICS) in early-group patients was associated with lower symptoms, such as shortness of breath and headache, compared to patients who in late-group patients. According to the results, our study showed that bronchodilators improved lung function, reduced symptoms, and enhanced the quality of life of COPD patient